本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Zealand Pharma A/S

17.59
+0.0000
成交量:- -
成交额:- -
市值:8.14亿
市盈率:-4.56
高:17.59
开:17.59
低:17.59
收:17.59
数据加载中...
2022/09/20

自愿退市

25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2022/09/20

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/09/20

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/05/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/04/05

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/25

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/10/04

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/12

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/12

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/26

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/19

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/11

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/11

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/04/09

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]